Gland Pharma Limited — Updates, 04-03-2026: Press Release
04-03-2026 | 11:04 am
04-03-2026 | 11:04 am
Gland Pharma secured tentative USFDA approval for Brimonidine Tartrate Ophthalmic Solution (OTC), used for eye redness. The reference product's US sales were approximately USD 39 million, signalling a potential market opportunity.
No comments yet. Be the first to comment!
